Logo - International Journal of Pharmaceutical Compounding

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2006 - Veterinary Compounding
View All Articles in Issue

Abstract:  National Institute of Occupational Safety and Health Publication No. 2004–165, Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings, was published in 2004 to increase the awareness of healthcare workers and other professionals about the health risks of working with hazardous drugs and to provide measures for protecting their health. The health risks to employees who prepare or administer hazardous drugs in the workplace is influenced by many factors, and each compounding facility is responsible for developing its own list of hazardous drugs and for creating standard operating procedures to reduce risks as much as possible for employees. To provide employees with the greatest protection, employers should (1) implement necessary administrative and engineering controls, and (2) assure that the workers use sound procedures and proper protective equipment for handling hazardous drugs.

Related Keywords: United States Pharmacopeia, hazardous drugs, drug safety, compounded sterile preparations, chemotherapy agents, drug contamination, regulation, Occupational Safety and Health Administration, OSHA, National Institute for Occupational Safety and Health, NIOSH, employee exposures, safe workplace, Loyd V Allen Jr, PhD, RPh

Related Categories: LEGAL, QUALITY CONTROL, PROFESSIONAL ISSUES

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=2495

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products